SensDx S.A. of Warschau at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

SensDx S.A.

Postepu 14 B, 02-676 Warschau

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Our range of products

Product categories

  • 01  Electromedical equipment / medical technology
  • 01.01  Diagnostics
  • 01.01.13  Other diagnostic equipment

Our products

Product category: Other diagnostic equipment

Mobi SensDx Reader

Our reader, Mobi SensDx,  provides diagnostics technology based on ultrasensitive microsensors modified with biological particles. The particles found on the surface of the microsensor are carefully selected by our biotech team to fit specific bacterium or virus. During the assay, presence of pathogen on microsensor is measured through electrochemical impedance spectroscopy.  This enables SensDx App to clearly identify the bacterium or virus causing an infection.

Our technology facilitates pathogen detection at a very early stage of infection, which allows for a fast response of the physician, selection of the right treatment allows to avoid the use of antibiotics if a viral infection is detected. Moreover, with our technology it is also possible to detect oncological, DNA and RNA markers.

To operate, the device requires a computer running Microsoft Windows 10. We are working on bringing solutions to mobile devices.

More Less

Product category: Other diagnostic equipment

Flu SensDx Assay

The flu virus is the most common cause of upper respiratory tract infections. In some parts of the world and in some risk groups (the elderly, newborns, individuals with a weak immune system) it is also a common cause of death. According to the World Health Organisation, between 2 and 5 million people in the world develop the flu every year, of whom as many as 500,000 are recorded as fatal cases.

The symptoms of the flu are similar to other upper respiratory tract infections caused by bacteria, which is why antibiotic treatment is often used unnecessarily, affecting the body negatively and causing antibiotic resistance (which is a growing issue in case of many bacterial infections). The Flusensor detects the flu virus at an early stage of development, which effectively prevents it from spreading.  Efficient and precise identification allows for the use of the right treatment without the need to administer antibiotics.

More Less

Product category: Other diagnostic equipment

SARS-CoV-2 SensDx

The SARS-CoV-2 SensDx assay provides rapid testing solution for clinical and non-clinical setting during COVID-19 pandemic. 

The assay is designed for professional use by medical or paramedical personnel. The procedure is easy to use and does not require any specific training.

The following is required to perform an assay:

  • Mobi SensDx electrochemical impedance spectroscopy reader
  • Microsoft Windows 10 computer, with an available USB-A port
  • SARS-CoV-2 SensDx assay kit containing microsensor, swab, buffer and sample tube
Assay results are for qualitative identification of SARS-CoV-2 virus presence in a throat swab. The swab is placed in the sample tube filled with a buffer solution and then tested on SARS-CoV-2 SensDx Microsensor for the presence of SARS-CoV-2 specific proteins using electrochemical impedance spectroscopy. The results presented are positive, negative, a trace amount of the virus or non-diagnostic (indicating microsensor failure or test procedure error).

More Less

About us

Company portrait

The creator of SensDx is Dawid Nidzworski, Doctor of Biological Sciences specialising in Biochemistry, who, together with Artur Kupczunas, Piotr Krych and Tomasz Gondek, established SensDx (formerly Eton Group) in September 2014